Guerbet Partners with NATIXIS ODDO BHF for New Liquidity Contract

Guerbet's New Liquidity Contract with NATIXIS ODDO BHF

Guerbet (FR0000032526 GBT), recognized globally as a pivotal player in medical imaging, is setting a new course by engaging NATIXIS and ODDO BHF for the management of its liquidity contract, effective from February 3, 2025. This partnership marks a significant transition, as it follows the conclusion of a previous liquidity agreement that began on March 9, 2022.

Objectives of the Liquidity Contract

This recently established contract adheres to the guidelines set forth by the Autorité des marchés financiers (AMF), ensuring that it follows accepted market practices. Specifically, it aligns with AMF Decision n°2021-01, designed to facilitate a smoother trading environment for shares on the regulated Euronext Paris market.

Allocation of Resources

In preparation for the upcoming contract, the liquidity account has been sufficiently resourced. Notably, it includes the allocation of 10,996 shares and a total of €340,083.86, ensuring that the contract will have the means to operate effectively and support the trading of the company’s shares.

Operational Guidelines and Termination Conditions

The effective management of this liquidity contract entails specific operational guidelines. The contract may be paused under certain circumstances, including compliance with specific AMF articles or shareholder directives regarding share thresholds. Furthermore, the agreement is flexible, allowing Guerbet to terminate the contract at any time, while NATIXIS and ODDO BHF can also end their participation with a notice period of 15 days.

About Guerbet

Guerbet is dedicated to enhancing healthcare through its pioneering work in medical imaging. The company has built a strong foundation over its 95 years of innovation in contrast media. With over 2,600 employees across the globe, Guerbet invests 10% of its annual sales into research and development, ensuring the ongoing advancement of its diverse portfolio which encompasses pharmaceutical products, medical devices, and cutting-edge digital solutions.

Commitment to Research and Innovation

Guerbet places a high value on continuous innovation, which is evident in its commitment to research and development. With centers located in France, the United States, and Israel, the company strives to remain at the forefront of advancements in diagnostic and interventional imaging, solidifying its position as a leader in the industry.

Financial Performance

In 2023, Guerbet demonstrated robust financial strength, generating revenue of €786 million. This solid performance underlines the company's capability in navigating the challenges of the medical imaging market, reinforcing its commitment to quality and excellence in healthcare solutions.

Contacts for Further Information

For additional inquiries, Guerbet has made communication channels available:

Guerbet Contacts:
Jérôme Estampes, Chief Financial Officer: +33 1 45 91 50 00
Christine Allard, Head of Public Affairs and Communications: +33 6 30 11 57 82

Seitosei Actifin Contacts:
Marianne Py, Financial Communication: +33 1 80 48 25 31
Jennifer Jullia, Press: +33 1 56 88 11 19

Frequently Asked Questions

What is the main purpose of the liquidity contract?

The liquidity contract aims to enhance the trading of Guerbet's shares on Euronext Paris.

How long will the new liquidity contract be in effect?

The contract is set for one year but is tacitly renewable thereafter.

What resources were allocated to the liquidity account?

The liquidity account currently holds 10,996 shares and €340,083.86.

Can the liquidity contract be terminated early?

Yes, Guerbet can terminate the contract at any time, while NATIXIS and ODDO BHF must give 15 days' notice to end their involvement.

What is Guerbet's commitment to innovation?

Guerbet invests 10% of its sales into research and development to remain at the forefront of medical imaging innovations.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.